Treatment for OUD is currently dominated by opioid agonist therapies that are highly regulated due to their liability for abuse.

Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.

Kourtney Kardashian has gone all-in on her passion for health and wellness -- and now, her Lemme vitamin and supplement brand ...

Conagra and General Mills are among the food companies offering special options for people on GLP-1 drugs, but the products ...

A doctor from the University of Palermo in Italy has published a case study of an adult cocaine user who experienced reduced withdrawal symptoms when given GLP-1 therapy. In the case study published ...

Roche has reported early-stage clinical data with an oral GLP-1 agonist acquired as part of its $3.1 billion takeover of Carmot Therapeutics as it tries to catch up with the leaders in the fast ...